Infertility, Male Clinical Trial
Official title:
Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle
Verified date | August 2021 |
Source | University Hospital, Antwerp |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Infertility affects about 10% of all couples and is defined by a failure to achieve a clinical pregnancy within a year of regular unprotected sexual intercourse. Up to one third of these couples will not have an identifiable cause after routine investigation, id est idiopathic infertility. The current diagnosis of male infertility relies on the World Health Organization (WHO) 2010 criteria which focus on concentration, motility and morphology in comparison to cut-off values of a fertile population. Alas, the relevance of the conventional semen analysis for the choice of treatment and the predictive value for an infertile couple with idiopathic or mild male infertility embarking on medically assisted reproduction (MAR) remains questionable. In other words, there is a strong clinical need to distinguish fertile from infertile men through new sperm function testing and to be able to select both the patient population who will benefit from MAR as well as the type of treatment. Numerous studies utilizing different techniques for assessing sperm DNA fragmentation support the existence of a significant association between sperm DNA damage and pregnancy outcomes. In this prospective cohort study the investigators aim to study the role of sperm DNA fragmentation analysis in selecting the patient who will benefit from intra-uterine insemination (IUI) therapy since IUI is still considered the first step in MAR and is performed at a large scale in Belgium and worldwide.
Status | Completed |
Enrollment | 120 |
Est. completion date | June 30, 2021 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: Couples seeking fertility treatment after at least 12 months of unprotected intercourse are eligible. All couples underwent basic fertility investigations which included semen analysis, evaluation of menstrual cycle, and tubal patency testing. Exclusion Criteria: Double sided tubal disease, severe endometriosis (classified as revised American Society for Reproductive Medicine stage III or IV), premature ovarian failure, and known endocrine disorders (such as Cushing's syndrome or adrenal hyperplasia), azoƶ- or necrozoospermia |
Country | Name | City | State |
---|---|---|---|
Belgium | Universitair Ziekenhuis Antwerpen | Edegem | Antwerp |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Antwerp | Universiteit Antwerpen |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | DNA fragmentation as a predictor of clinical pregnancy and live birth rate | DNA fragmentation as evaluated by TUNEL assay. | up to 36 months | |
Secondary | DNA fragmentation in the total and vital fraction before and after density gradient in the diagnostic sample (pre-IUI) | DNA fragmentation as evaluated by TUNEL assay | up to 36 months | |
Secondary | DNA fragmentation in the total and vital fraction before and after density gradient in the therapeutic sample (IUI sample) | DNA fragmentation as evaluated by TUNEL assay | up to 36 months | |
Secondary | DNA fragmentation in relation to the cumulative clinical pregnancy and cumulative live birth rate | DNA fragmentation as evaluated by TUNEL assay. | up to 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Recruiting |
NCT04955782 -
Abstinence Period and Semen Quality
|
||
Recruiting |
NCT05506722 -
Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity
|
N/A | |
Not yet recruiting |
NCT03988361 -
Selection of Non Apoptotic Human Sperm for in Vitro Fertilization by Using Magnetic Activated Cell Sorting (MACS)
|
||
Not yet recruiting |
NCT05597631 -
G-IVF and Sperm Parameters
|
N/A | |
Completed |
NCT05919186 -
Effects of Antioxidant Supplementation of Culture Media on IVF Embryos
|
N/A | |
Recruiting |
NCT03588949 -
Role of Nutritional Support in Idiopathic Male Infertility
|
N/A | |
Recruiting |
NCT03527043 -
Impact of Escitalopram on Sperm DNA Fragmentation
|
Phase 2 | |
Completed |
NCT02932865 -
Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility
|
||
Completed |
NCT02310087 -
Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures
|
N/A | |
Completed |
NCT00385346 -
Expressive Writing in Male Infertility
|
N/A | |
Completed |
NCT04509583 -
The Role of Micro Nutrient Supplement in Improvement of the Sperm DNA Fragmentation
|
N/A | |
Recruiting |
NCT04144244 -
Comparison of the Effect of Microchip and Density Gradient Methods in Intrauterine Insemination Cycles
|
N/A | |
Recruiting |
NCT04452305 -
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
|
N/A | |
Completed |
NCT05461079 -
Sperm Phenotype and Differentially Methylated Regions
|
||
Recruiting |
NCT05205733 -
Expanding Fertility Care to Poor and Low Resourced Settings Study
|
N/A | |
Completed |
NCT03960229 -
The Evaluation of the Effect of Microfluidic Sperm Sorting Chip 'Labs-on-a-chip' on IVF Success in Male Factor
|
N/A | |
Not yet recruiting |
NCT06050031 -
Level of DNA-fragmentation Before and After Antioxidant-based Therapies in Male Infertility
|
||
Not yet recruiting |
NCT03090438 -
IVF Outcomes After Varicocele Repair
|
N/A | |
Recruiting |
NCT03968367 -
To Study the Effect of Magnetic Activated Sperm Sorting on the Outcome of in Vitro Fertilization-embryo Transplantation
|
N/A |